Pooling of SARS-CoV-2 samples to increase molecular testing throughput
- PMID: 32805524
- PMCID: PMC7396208
- DOI: 10.1016/j.jcv.2020.104570
Pooling of SARS-CoV-2 samples to increase molecular testing throughput
Abstract
Background: SARS-CoV-2 testing demand has outpaced its supply. Pooling samples for lower risk populations has the potential to accommodate increased demand for SARS-CoV-2 molecular testing.
Objective: To evaluate the sensitivity, specificity, and reproducibility of 4-way pooling of SARS-CoV-2 specimens for high-throughput RT-PCR.
Study design: Individual samples were pooled 1:4 through automated liquid handling, extracted, and assayed by our emergency use authorized CDC-based RT-PCR laboratory developed test. Positive samples were serially diluted and theoretical and empirical PCR cycle thresholds were evaluated. Thirty-two distinct positive samples were pooled into negative specimens and individual CTs were compared to pooled CTs. Low positive samples were repeated for reproducibility and 32 four-way pools of negative specimens were assayed to determine specificity.
Results: Four-way pooling was associated with a loss of sensitivity of 1.7 and 2.0 CTs for our N1 and N2 targets, respectively. Pooling correctly identified SARS-CoV-2 in 94 % (n = 30/32) of samples tested. The two low positive specimens (neat CT > 35) not detected by pooling were individually repeated and detected 75 % (n=6/8) and 37.5 % (n = 3/8) of the time, respectively. All specimens individually determined negative were also negative by pooling.
Conclusion: We report that 1:4 pooling of samples is specific and associated with an expected 2 CT loss in analytical sensitivity. Instead of running each sample individually, pooling of four samples will allow for a greater throughput and conserve scarce reagents.
Keywords: COVID-19; Diagnostics; Disease surveillance; Pooling; RT-PCR; SARS-CoV-2.
Copyright © 2020 Elsevier B.V. All rights reserved.
Conflict of interest statement
The authors declare no conflict of interest.
Figures

Comment in
-
Pooled Testing for Surveillance of SARS-CoV-2 in Asymptomatic Individuals.J Clin Virol. 2020 Nov;132:104619. doi: 10.1016/j.jcv.2020.104619. Epub 2020 Sep 3. J Clin Virol. 2020. PMID: 32920431 Free PMC article. No abstract available.
References
-
- Meyer Robinson A.C.M. The Atlantic; 2020. A Dire Warning From COVID-19 Test Providers.https://www.theatlantic.com/science/archive/2020/06/us-coronavirus-testi...
-
- T.A.J.-C. J. Scott Trubey, Georgia sees testing system strained with rise in COVID-19 cases, Ajc. (n.d.). https://www.ajc.com/news/state--regional/georgia-sees-testing-system-str....
-
- Quest Diagnostics Media Statement about COVID-19 Testing, Quest Diagnostics Newsroom. (n.d.). https://newsroom.questdiagnostics.com/COVIDTestingUpdates.
-
- O. of the Commissioner . FDA; 2020. Coronavirus (COVID-19) Update: FDA Issues First Emergency Authorization for Sample Pooling in Diagnostic Testing.https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19...
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous